Superworth

Lexaria Bioscience profit margin LEXX

Gross, operating and net profit as a share of revenue over the last twelve months, from 2011.

Net margin, 12 months
n/m
not a meaningful number
Peer median
8.6%

Lexaria Bioscience's net margin works out at −3986% over the last twelve months, but it is not a meaningful number: a margin outside minus 100% to 100% is moved by items that are not sales.

Profit margin over time

GrossNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginGross margin
FY2025n/a99.6%
FY2024n/a99.0%
FY2023n/a86.1%
FY2022n/a71.9%
FY2021n/a75.7%
FY2020n/a33.0%
FY2019n/a89.7%
FY2018n/a94.2%
FY2017n/a53.3%
FY2016n/a−12.0%
FY2015n/an/a
FY2014n/an/a
FY2011−47.5%41.1%
FY2010n/an/a

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a year
Q3 FY26n/an/a
Q2 FY26n/an/a
Q1 FY26n/an/a
Q4 FY25n/an/a
Q3 FY25n/an/a
Q2 FY25n/an/a
Q1 FY25n/an/a
Q4 FY24n/an/a
Q3 FY24n/an/a
Q2 FY24n/an/a
Q1 FY24n/an/a
Q4 FY23n/an/a

Against its peers

Companies in Healthcare nearest Lexaria Bioscience's size, closest first, today.

CompanyProfit margin
LEXXLexaria Biosciencen/m
OXBROXBRIDGE RE HOLDINGS4.7%
EDUCEducational Development8.6%
GTIMGood Times Restaurants1.7%
MDRRMedalist Diversified80.2%
BCGBinah Capital2.2%
VIPVulcan Infrastructure & Power1.0%
MXCMexco Energy23.3%
CKXCKX Landsn/m
MSGMMotorsport Games16.2%
ATCHAtlasClear9.8%
Peer median8.6%

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on Lexaria Bioscience

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.